Dafra Pharma International

Dafra Pharma International is a Belgian pharmaceutical company that specializes in the development, marketing, and distribution of high-quality medicines specifically tailored for the African market. Established in 1997, the company has built a robust portfolio focusing on infectious diseases, particularly malaria, where it is a recognized leader with products like Co-Artesiane. Beyond antimalarials, Dafra Pharma provides a wide range of therapies in cardiology, gastroenterology, and internal medicine. The company operates with a mission to bridge the gap between European manufacturing standards and the healthcare needs of developing nations. With a presence in over 30 countries, Dafra Pharma utilizes an extensive network of medical representatives to ensure professional distribution and education.